Qiuyuan Wen Selected Research

Ductal Carcinoma

1/2018	Elevated expression of IRS-1 associates with phosphorylated Akt expression and predicts poor prognosis of breast invasive ductal carcinoma.
10/2014	[p53 protein expression in HER2-negative breast invasive ductal carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiuyuan Wen Research Topics

Disease

27	Neoplasms (Cancer) 05/2022 - 01/2014
13	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2014
11	Nasopharyngeal Carcinoma 04/2020 - 01/2014
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2016
7	Lymphatic Metastasis 01/2017 - 01/2014
6	Carcinogenesis 01/2021 - 01/2017
5	Adenocarcinoma of Lung 06/2022 - 01/2019
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 08/2020 - 01/2015
3	Breast Neoplasms (Breast Cancer) 02/2017 - 01/2015
2	Pathologic Processes 01/2020 - 03/2019
2	Ductal Carcinoma 01/2018 - 10/2014
2	Hyperplasia 01/2018 - 01/2014
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2020
1	Disease Progression 10/2019
1	Carcinoma (Carcinomatosis) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Ulcer 01/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2014

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2014
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
6	Eukaryotic Initiation Factor-4EIBA 01/2022 - 01/2014
5	Peptide Initiation Factors (Initiation Factor)IBA 01/2022 - 01/2014
5	flotillinsIBA 04/2020 - 01/2014
4	Messenger RNA (mRNA)IBA 06/2022 - 11/2019
4	Phosphotransferases (Kinase)IBA 01/2022 - 01/2014
3	Everolimus FDA Link 01/2022 - 05/2016
3	TOR Serine-Threonine KinasesIBA 01/2021 - 05/2016
3	CGP 57380IBA 10/2019 - 05/2016
2	Small Interfering RNA (siRNA)IBA 06/2022 - 01/2015
2	CateninsIBA 01/2021 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2017
2	B7-H1 AntigenIBA 01/2021 - 10/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 02/2017
2	Insulin Receptor Substrate ProteinsIBA 01/2018 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2017 - 01/2015
2	ParaffinIBA 02/2017 - 01/2017
2	Chaperonin 10IBA 01/2017 - 01/2017
2	LipidsIBA 07/2015 - 01/2015
1	jujuboside AIBA 06/2022
1	Ribosomal Protein S6IBA 05/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	LigandsIBA 01/2021
1	MucinsIBA 08/2020
1	Indicators and Reagents (Reagents)IBA 08/2020
1	tyrosine receptor (receptor, tyrosine)IBA 08/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Biological ProductsIBA 12/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 02/2017
1	Untranslated RNA (Noncoding RNA)IBA 02/2017
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2017
1	ChaperoninsIBA 01/2017
1	Cyclin D1IBA 01/2017
1	VimentinIBA 01/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	CalponinsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 05/2016
1	Sirolimus (Rapamycin)FDA Link 05/2016
1	MTOR InhibitorsIBA 05/2016
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 04/2016
1	DNA Methyltransferase 3AIBA 03/2016
1	Phenobarbital (Luminal)FDA Link 01/2015
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2016
4	Radiotherapy 01/2017 - 01/2014
3	Drug Therapy (Chemotherapy) 12/2019 - 01/2014
1	Aftercare (After-Treatment) 01/2022
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 02/2017
1	Laryngectomy 01/2017